89zr-panitumumab
Showing 1 - 1 of 1
Pancreas Cancer Trial in Stanford (89Zr-panitumumab)
Suspended
- Pancreas Cancer
- 89Zr-panitumumab
-
Stanford, CaliforniaStanford University
Jun 15, 2022